Willis Johnson & Associates’s Thermo Fisher Scientific TMO Stock Holding History

Willis Johnson & Associates’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-382	Closed	-$221K	–	211
2025 Q4	$221K	Sell	382 -35	-8%	-$19.8K	0.01%	165
2025 Q3	$202K	Buy	+417	New	+$194K	0.01%	181
2025 Q2	–	Sell	-437	Closed	-$218K	–	181
2025 Q1	$218K	Sell	437 -2	-0.5%	-$1.08K	0.02%	151
2024 Q4	$229K	Buy	439 +75	+21%	+$41.2K	0.02%	137
2024 Q3	$225K	Sell	364 -34	-9%	-$20.1K	0.02%	152
2024 Q2	$220K	Buy	398 +44	+12%	+$25.2K	0.02%	143
2024 Q1	$206K	Buy	+354	New	+$199K	0.02%	147
2022 Q1	–	Sell	-340	Closed	-$227K	–	111
2021 Q4	$227K	Buy	+340	New	+$212K	0.03%	90

Other funds holding TMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Willis Johnson & Associates's TMO Position: Q1 2026 in Review

Willis Johnson & Associates sold out of Thermo Fisher Scientific (TMO) in Q1 2026, closing a stake of 382 shares — an estimated $221K sold.

Willis Johnson & Associates first reported a position in TMO in Q4 2021 and held it in 8 quarters. The position peaked at $229K in Q4 2024. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

Willis Johnson & Associates reported no remaining Thermo Fisher Scientific position as of Q1 2026 after selling out during the quarter.
Willis Johnson & Associates sold 382 Thermo Fisher Scientific shares in Q1 2026, an estimated $221K.
Willis Johnson & Associates first reported a position in Thermo Fisher Scientific in Q4 2021 and held it in 8 quarters.
Willis Johnson & Associates's Thermo Fisher Scientific position peaked at $229K in Q4 2024.
2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Willis Johnson & Associates's 13F filing for Q1 2026, filed 23 Apr 2026.